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Quality of life (QOL) is described as a multidimensional construct 
incorporating an individual’s subjective perception of physical, 
emotional, and social wellbeing, including both a cognitive and 
an emotional component.[1] Health-related QOL (HRQOL) is 
increasingly being recognised as an important outcome of health, 
representing the ultimate goal of all healthcare interventions.[2] 
Conventional outcome assessment for diabetes mellitus (DM) 
relies on laboratory indicators, primarily glycosylated haemoglobin 
(HbA1c), and complications.[3] However, exclusive reliance on clinical 
outcomes does not necessarily reflect a patient’s perception of his/
her health. Management regimens that require changes in lifestyle 
and behaviour can influence daily functioning and general wellbeing. 
HRQOL is therefore increasingly being used as an outcome indicator 
alongside traditional biomarkers.[3]
Guidelines for the treatment of type 2 DM emphasise that one of 
the primary objectives is to improve HRQOL.[2] Studies show that 
HRQOL is associated with the duration of diabetes, age, gender, 
diabetic complications, comorbid diseases and the severity of the 
disease itself.[2]
Patients with diabetes, like those with many other chronic diseases, 
are less concerned with clinical biomarkers such as HbA1c, blood 
pressure or lipid levels, and more concerned with how the disease 
will affect their lives in various domains.[4] These domains include 
physical and social function, emotional and mental health, the 
burden of the illness and stigma attached to it, and how treatment will 
impact on their daily life.[4]
There is a dearth of South African (SA)-specific information 
on HRQOL and diabetes. Country-specific HRQOL information 
may provide improved insight, and potentially lead to improved 
management of diabetes. The objective of this study was to better 
understand the effects of diabetes on HRQOL in an SA tertiary-level 
hospital setting.
Methods 
Ethical approval was received from the Human Research Ethics 
Committee, University of the Witwatersrand, Johannesburg (protocol 
no. M120536). This was a clinical audit, cross-sectional in nature, 
and a descriptive study of consecutive patients attending the diabetes 
clinic at Helen Joseph Hospital (HJH), a level 3/tertiary state hospital 
in Johannesburg, over a 3-month period. The study population 
consisted of 200 patients attending the diabetes clinic at HJH. This 
sample size was chosen to include all patients who met the inclusion 
criteria and obtain a fair representation of the population attending 
the diabetes clinic.
Inclusion criteria. Patients with type 2 DM who had attended the 
specialist diabetes clinic for ≥6 months.
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Background. Diabetes mellitus (DM) is a chronic metabolic disease that potentially causes debilitating and life-threatening complications, 
demands a lifestyle change, and has important implications with regard to wellbeing and health-related quality of life (HRQOL).
Objectives. To: (i) determine the HRQOL of a sample of patients with type 2 diabetes; (ii) describe the demographics (age, gender, and 
smoking and alcohol use) of the population studied; (iii) document the following parameters, which are important in determining the 
control and severity of type 2 diabetes: (a) glycosylated haemoglobin (HbA1c), (b) total amount of insulin required per day (if on insulin 
therapy), (c) body mass index (BMI), and (d) exercise compliance; (iv) determine whether there was an association between any or all of the 
above parameters and the HRQOL of these patients; and (v) determine whether coexisting diseases (hypertension (HT) and dyslipidaemia) 
were present, and compare HRQOL between diabetic patients with and without these diseases.
Methods. This was a cross-sectional and descriptive study of 200 patients attending the diabetes clinic at Helen Joseph Hospital, 
Johannesburg, South Africa. HRQOL assessments were made using the Diabetes 39 (D-39) questionnaire, which patients filled in once 
consent had been obtained and if they fulfilled the inclusion criteria. Patients’ questionnaire forms were then analysed with regard to their 
demographics (age and gender), exercise regimen, smoking and alcohol history, employment status, living arrangements, age of diagnosis 
of DM, and concurrent use of antihypertensive and cholesterol-lowering drugs. The patients’ files were analysed and various clinical 
parameters were noted (HbA1c, lipogram, BMI, number of insulin units used per day, and whether any antihypertensive and/or lipid-
lowering drugs were used).
Results. There was an association between HRQOL and HbA1c, and between HRQOL and HT and dyslipidaemia.
Conclusions. No association was found between HRQOL and other clinical parameters, namely number of insulin units used per day, 
exercise, BMI, lipogram and the use of oral hypoglycaemic agents. Demographic parameters (age, gender, age at diagnosis, employment 
status and living arrangements) were also shown to have no impact on HRQOL. We found no association between HRQOL in patients who 
consumed alcohol and smoked cigarettes and in those who did not.
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Exclusion criteria. Patients with type 1 
DM or blindness, or from whom informed 
consent could not be obtained.
Fig. 1 shows the study flow. 
Measuring HRQOL in diabetes
Various instruments, generic and disease 
speci fic, have been developed to measure 
HRQOL in diabetes. Generic instruments 
are designed to investigate aspects of health 
that are of universal importance, and allow 
comparisons of HRQOL among different 
groups of patients. These may be useful for 
capturing the additional HRQOL deficits 
associated with comorbid diseases and their 
respective treatments, such as hypertension 
(HT), dyslipidaemia and depression, as they 
incorporate a wider range of dimensions 
of HRQOL. In contrast, diabetes-specific 
instruments capture the specific impact that 
diabetes has on a patient’s daily functioning 
and wellbeing and hence on their QOL, and 
so could be more sensitive to small clinically 
important differences. Reviews have shown 
that the dimensions covered by diabetes-speci-
fic instruments vary, but they generally include 
physical and psychological functioning, 
fulfilment of the patient’s social role, diabetes 
control and satisfaction with treatment.[2,3]
Among the best-known generic instru-
ments are the Short-Form Health Survey 
(SF-36) (this is the shortened version of 
the RAND Corporation’s MOS Functioning 
and Well-being profile), the Quality of 
Well-being (QWB) scale, its successor, the 
Quality of Well-being Self-Administered 
Scale (QWB-SA), and the Euroqol 5D and 
the COOP/WONCA charts.[2,5] The Medical 
Outcomes Study 36-Item Short-Form 
Health Survey (SF-36) is a commonly used 
generic instrument for diabetes, while the 
Diabetes-39 (D-39) questionnaire has been 
demonstrated to have good psychometric 
properties.[2]
The D-39 questionnaire
The D-39 questionnaire[5] (Appendix 1) was 
used in this study. Developed by Boyer and 
Earp, this is a 39-item instrument that was 
designed to assess HRQOL in patients with 
type 1 and type 2 DM. The developers did 
not give express consideration to face/content 
validity, but used extensive literature reviews, 
existing QOL questionnaires and interviews 
with health professionals and patients with 
diabetes.[5] Written permission to use the 
D-39 questionnaire was obtained from them.
The D-39 questionnaire encompasses meas-
ure ments of energy and mobility, diabetes 
control, anxiety and worry, social burden and 
sexual functioning. Patients are asked how 
much the quality of their life was affected by 
a wide range of aspects of diabetes illness and 
its treatment in the past month. Items are 
administered using seven response categories, 
ranging from not affected at all (score = 1) to 
extremely affected (score = 7). The detailed 
D-39 scoring instructions and further 
information in this regard are available from 
the author (reyna.daya13@gmail.com). The 
reliability of the questionnaire is acceptable, 
with a Cronbach alpha of 0.81 - 0.93 for all 
the subscales. The construct validity has been 
compared with the widely used SF-36 and 
found to be very satisfactory.
The D-39 questionnaire has been recom-
mended for use in research and clinical 
settings. The instrument provides evidence 
for validity and reliability, includes several 
domains that cover various aspects of 
QOL, and is therefore applicable to a wide 
population of patients.[5] It is one of few 
diabetes-specific QOL measures that have 
been shown to be responsive to changes in 
health status.[5,6] Importantly, it does not 
impose a definition of QOL upon patients, 
but instead allows them to respond in the 
context of their personal conceptualisation 
of QOL.[5] These attributes make the instru-
ment highly patient-centered, one of the 
most critical components of any patient-
assessed QOL measure.[5,6]
The following measurements of the 
severity and control of diabetes were used 
in this study:
• Demographics (age, gender)
• Smoking pack-year history (number of 
cigarettes smoked per day divided by pack 
of 20 cigarettes multiplied by number of 
years smoked). Factors such as brand and 
strength (nicotine and tar content) were 
not measured.
• Alcohol units consumed per week. The 
study did not distinguish between types 
of alcohol consumed (wine, spirits, etc.).
• Number of insulin units used per day. 
The study did not distinguish between the 
types of insulin used (i.e. rapid- or long-
acting insulin) or the number of times 
a patient injected him/herself (daily or 
twice-daily regimens).
• Use of antihypertensive or lipid-lowering 
medication or oral hypoglycaemic agents 
(OHAs)
• Exercise. Patients were considered to 
be exercising if they attended a gym/
sporting/recreational facility at least three 
times a week or if they reported doing 
an exercise routine by themselves for at 
least 30 minutes, three times a week. 
This routine must have been followed 
for at least 1 month. The study did not 
distinguish between the grades of physical 
activity.
• Weight was measured using a standard 
calibrated scale placed on the floor. 
Patients were weighed while standing 
barefoot and were instructed not to hold 
onto any form of support.
• Height was measured with a tape measure 
and recorded to the nearest centimetre. 
The patient was requested to stand 
barefoot with his/her heels together and 
touching the wall, with his/her back 
against a wall.
• Body mass index (BMI) was calculated 
using Quetelet’s formula (weight (kg)/
height2) and defined using the World 
Health Organization (WHO) classification 
(underweight <20 kg/m2), normal 20 - 
24.9 kg/m2, overweight >25 - 29.9 kg/m2, 
and obese >30 kg/m2).
200 patients with DM
attending the diabetes
clinic at HJH
Fit inclusion criteria
Informed consent
D-39 questionnaire
•  Energy and mobility
•  Diabetes control
•  Anxiety and worry 
•  Social burden
•  Sexual function
Demographics questionnaire
•  Age
•  Sex
•  Age at diagnosis
•  Alcohol/smoking history
•  Employment status
•  Exercise
•  Marital status
•  Living arrangements
Files evaluated
•  No. of insulin units
•  OHA use
•  Antihypertensive use
•  BMI
•  Lipogram
•  HbA1C
Data analysis
Fig. 1. The study flow.
RESEARCH
920       September 2016, Vol. 106, No. 9
• Most recent lipid profile
• Latest HbA1c level.
Statistical analysis
All data collected were extrapolated onto an Excel 2010 spreadsheet 
(Microsoft, USA), and STATISTICA 12 (StatSoft, USA) was used for 
descriptive statistics (means, medians, modes, standard deviations 
(SDs) and interquartile ranges (IQRs), where appropriate). In 
addition to the descriptive statistics, a principal component analysis 
(PCA) was performed. The PCA allowed for reduction in the number 
of variables for analysis and subsequently for the variables explaining 
the largest amount of variance to be analysed in the context of the 
objectives of the study.
Data were checked for normality (normal distribution), but 
normality is often not achieved in social studies. In order to mitigate 
against this, data were bootstrapped 100 000 times to ensure that 
sufficient variance existed in the data and that the results obtained 
could be interpreted confidently.
To assess whether there were factors influencing QOL, associations 
between variables were analysed using Pearson’s correlation coef-
ficient. It is important to note that the associations should not to be 
interpreted as causal factors.
Continuous data were presented as median values with IQRs, and 
categorical data were described using proportions. Student’s t-test for 
unpaired data was performed to compare medians between groups 
when the data were normally distributed, and the Mann-Whitney 
test was used when the data were not normally distributed. Fisher’s 
exact test was used to compare categorical variables between groups. 
A p-value of <0.05 was considered significant.
Results
Data were collected from 220 patients. Twenty patients were excluded 
from the study owing to an incompletely filled-in questionnaire 
(n=14) or lack of data recorded in the file (n=6). Ten patients were 
approached but refused to participate in the study. Table 1 shows the 
demographic profile of the patients analysed.
Diabetes control
Khanna et al.[7] report that on a transformed scale of 0 - 100, a score 
closer to 0 indicates a better QOL and a score closer to 100 a worse 
QOL. The mean score for diabetes control in our study was 43.65.
Anxiety and worry
The mean score for anxiety and worry in our study was 53.77 (mean 
for males 51.58, mean for females 55.42). Nineteen patients had a 
score of 71.43 (the mode, or most frequently observed score) (range 
7.14 - 235.71)
Social burden
Possible scores for social burden ranged from 7.14 to 92.86. The mean 
score in our study was 32.76 (mean for males 30.66, mean for females 
34.34). The mode was 7.14, with 22 patients having this score.
Sexual function
The total mean score in our study was 51.76 (mean for females 45.66, 
mean for males 59.86). The mode was 7.14, with 35 patients having 
this score (range 2.38 - 92.86).
Energy and mobility
The total mean score in our study was 43.65 (mean for females was 
46.66 and for males 39.63). The mode was 36.90, with 12 patients 
having this score (range 7.14 - 92.86).
Overall ratings 
The five aspects of QOL in the D-39 questionnaire all affect HRQOL 
and are set out in Table 2. 
Table 1. Demographic and cohort characteristics of the study subjects
Parameter Results
Total patients, N 200
Gender, n (%)
Males 86 (43.0)
Females 114 (57.0)
Age (yr)
Mean (SD), median (range) 55.89 (12.52), 
58 (30 - 82)
Males, mean (SD) 53.29 (12.73)
Females, mean (SD) 57.85 (12.04)
Age distribution (years), n (%)
30 - 40 27 (13.5)
41 - 50 41 (20.5)
51 - 60 55 (27.5)
≥61 77 (38.5)
Age at diagnosis (years)
Mean (SD), median (range) 42.19 (10.74), 
40 (18 - 72)
Males, mean (SD) 41.34 (10.81)
Females, mean (SD) 42.82 (10.69)
Employment status, n (%)
Employed 49 (24.5)
Unemployed 151 (75.5)
Living arrangements, n (%)
Live alone 26 (13.0)
Live with others 174 (87.0)
Cigarette smoking, n (%)
Cigarette use (pack-years) 61 (30.5)
0.1 - 10 32 (16.0)
10.1 - 20 17 (8.5)
20.1 - 40 9 (4.5)
>40.1 3 (1.5)
No cigarette use 139 (69.5)
Alcohol consumption, n (%)
Consume alcohol 31 (15.5)
1 - 5 units per week 28 (14.0)
5.1 - 10 units per week 3 (1.5)
No alcohol consumed 169 (84.5)
OHAs with insulin use, n (%)
Metformin 130 (65.0)
Sulphonylurea 176 (88.0)
Exercise, n (%)
Regular exercise 106 (53.0)
No exercise 94 (47.0)
Continued ...
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While Table 2 indicates the HRQOL factors, further examination of 
the factors that individuals perceive as influencing QOL was done 
using a PCA (Table 3). The results show that sexual function, anxiety 
and worry and diabetes control are the main factors that influ-
ence HRQOL. PCA 1, representing the psychological component 
of HRQOL, was most influenced by sexual function, anxiety and 
worry, and social burden, while PCA 2, representing the physical 
effects of the diabetes, was influenced by diabetes control, and energy 
and mobility. Table 3 indicates that sexual function accounts for 
the most variation in the dataset of all the constructs that measure 
QOL. Significant associations between HRQOL and the parameters 
investigated are set out in Table 4.
Discussion
Our results indicate that a greater number of females than males 
responded to the questionnaire. While this does not mean that 
females are more susceptible to DM, respondent bias may be a 
possible explanation for the greater number of female respondents 
(n=114 v. 86). While the gender distribution may reflect the male/
female ratio of patients attending the diabetes clinic, analysing 
demographics was not the objective of the study, although it may 
prove to be a fruitful area for further research focusing specifically on 
gender. With this in mind, we did note interesting gender differences 
that may support earlier research conducted by authors such as Rubin 
and Peyrot,[1] who reported that HRQOL is better among diabetic 
men than among diabetic women.
We found a mean HRQOL score of 216.98 for males and 223.78 
for females. These scores indicate that females with DM may have 
a reduced QOL compared with males. Rubin and Peyrot[1] reported 
that males are more satisfied with their diabetes treatment regimen 
than women, and missed fewer days of work and fewer leisure 
activities as a result of DM. Furthermore, it has been reported that 
men with diabetes report less disease impact and greater treatment 
satisfaction than women.[8] These results are consistent with a study 
conducted in the Netherlands, which found that women with DM 
had significantly lower HRQOL scores than men.[9] The differences 
were explained as being due to gender differences in levels of obesity. 
The present study supports these results, as females were found to be 
more obese than males, and therefore supports the view that obesity 
may affect HRQOL and have an adverse impact on females.
There have been differing reports on age as a factor affecting 
diabetic patients’ QOL. Brown et al.[10] and Rubin and Peyrot[1] 
reported that age has no effect on QOL, but Redekop et al.[9] reported 
that it may have a negative effect. They attributed this to older people 
having lower levels of energy, physical activity and social functioning. 
Our results, however, indicated that there is no association between 
age and HRQOL. This finding is consistent with those of Brown et 
al.[10] and Rubin and Peyrot.[1] While we could not find an explanation 
Table 1. (continued) Demographic and cohort characteristics 
of the study subjects
Parameter Results
Insulin used/not used, and no. of units used per day, 
n (%)
Insulin used 199 (99.5)
0.1 - 40 63 (31.7)
40.1 - 80 89 (44.7)
80.1 - 120 25 (12.6)
120.1 - 160 3 (1.5)
160.1 - 20 4 (2.0)
No insulin use 1 (0.5)
Coexisting diseases, n (%)
HT 148 (74.0)
Dyslipidaemia 140 (70.0)
HT + dyslipidaemia 128 (64.0)
HbA1c (%), n (%)
≤7 28 (14.0)
7.1 - 7.9 28 (14.0)
8 - 8.9 23 (11.5)
9 - 9.9 41 (20.5)
≥ 10 80 (40.0)
Total cholesterol (mmol/L), n (%) 
≤4.5 (target level) 113 (56.5) 
4.6 - 4.9 22 (11.0) 
5.0 - 6.0 42 (21.0)
6.1 - 7.0 15 (7.5)
≥7.1 8 (4.0)
Triglyceride (mmol/L), n (%) 
≤1.7 (target level) 123 (61.5) 
1.8 - 2.5 38 (19.0)
2.6 - 3.5 23 (11.5)
3.6 - 4.5 11 (5.5)
≥ 4.6 5 (2.5)
HDL (mmol/L), n (%) 
≤1.2 (target level) 128 (64.0) 
1.3 - 2.0 60 (30.0)
2.1 - 3.0 8 (4.0)
3.1 - 4.0 1 (0.5)
≥4.1 3 (1.5)
LDL (mmol/L), n (%) 
≤1.8 (target level) 48 (24)
1.9 - 2.5 65 (32.5)
2.6 - 3.5 54 (27.0)
3.6 - 4.5 19 (9.5)
≥4.6 9 (4.5)
Blank 5 (2.5)
Continued ...
Table 1. (continued) Demographic and cohort characteristics 
of the study subjects
Parameter Results
BMI, n (%) 
Underweight (<20 kg/m2) 5 (2.5) 
Normal (20 - 24.9 kg/m2) 31 (15.5)
Overweight (>25 - 29.9 kg/m2) 41 (20.5)
Obese (>30 kg/m2) 123 (61.5)*
HDL = high-density lipoprotein; LDL = low-density lipoprotein.
*Of these, 60.2% (n=74) were female and 39.8% (n=49) male.
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for this in the literature, it may indicate that while physical health 
does decline with age, older people are not necessarily physically 
incapacitated and unenergetic.
The literature also reports conflicting findings on the relationship 
between duration of DM and HRQOL. The duration of DM has been 
reported to be associated with a decreased HRQOL.[11] A possible 
reason for this could be that the longer a patient has DM, the 
more complications may develop, thus worsening QOL. Rubin and 
Peyrot[1] and Redekop et al.[9] found no association between duration 
of DM and HRQOL, which is supported by the present study. No 
explanation for this could be found in the literature. A possible reason 
could be that the duration of DM does not necessarily correlate with 
good control, experience with treatment or level of complications, so 
not necessarily impacting on QOL.
The never-ending demands on the patient with diabetes, such as 
watching one’s diet, exercising regularly, monitoring blood glucose levels, 
and scheduling and planning life around one’s treatment, affects QOL 
in patients with both type 1 and type 2 DM.[1] It could be assumed that 
in addition to improving glucose control and reducing diabetes-related 
complications, improved adherence to a treatment regimen would lead 
to improved HRQOL, but some studies indicate that engaging in self-
management behaviour has a negative effect on QOL.[12,13] Watkins et 
al.[13] have suggested that dietary adherence may negatively affect QOL 
by increasing the level of perceived diabetes-related burden. People 
affected by DM are often restricted with regard to the amount, type and 
timing of food consumed (e.g. having to be aware of the glycaemic index 
of foods, eating mandatory meals at certain times, waiting for insulin to 
take effect before eating meals, etc.). These restrictions may negatively 
affect an individual’s QOL and their interaction with people around 
them, in their social lives and in the workplace.[13]
The present study found an association between a diabetic patient’s 
HRQOL and diabetes control as measured by HbA1c. The reasons 
are probably multifactorial, ranging from dietary restrictions to 
being deterred from engaging in social events and the time and 
commitment required to achieve good glycaemic and weight control.
Connel et al.[11] reported an association between socioeconomic 
status (income and level of education) and HRQOL. We used 
employment to indicate socioeconomic status, but found no 
association. This may be because employment is not a reliable means 
of assessing an individual’s socioeconomic status (e.g. employment 
status does not necessarily reflect financial status), so employment 
status may not have a significant impact on HRQOL. The fact that 
unemployment rates in SA are extremely high should also be kept 
in mind.
Exercise is closely related to weight control, which is reported to 
be an important factor in the management of diabetes. However, 
our results indicate that only half of the study population reported 
exercising regularly. This may be related to age (median 58 years), 
with older age being associated with a progressively more sedentary 
lifestyle, worsening the problem of DM and general HRQOL. 
Furthermore, physical strength decreases as an individual ages, and 
this may also be compounded by diabetes-related complications. 
Patients often do not perceive exercise as having a potential positive 
impact on QOL, which is further evidenced by the lack of an 
association between HRQOL and exercise.
Fal et al.[14] reported that BMI affects QOL. However, results from 
the present study provide no evidence for an association between 
the two, and indicate that while BMI and therefore weight may be 
significant in some specific medical conditions, they have no impact 
on DM. While being overweight may be linked to QOL, patients do 
not perceive it to be significant with specific reference to DM.
DM and HT appear to comparably impair HRQOL.[15] We found an 
association between HRQOL and concomitant HT and dyslipidaemia. 
DM and HT have comparable adverse effects on HRQOL.[15]
Table 2. Linear transformed ratings
Diabetes 
control
Anxiety 
and worry
Social 
burden
Sexual 
function
Energy 
and 
mobility
Mean total 43.65 53.77 32.76 51.76 38.91
Mean male 39.63 51.58 30.66 59.86 35.2
Mean female 46.66 55.42 34.34 45.66 41.71
Table 3. Principal component analysis
PCA 1 PCA 2
Sexual function 0.71 –0.69
Anxiety and worry 0.53 0.47
Social burden 0.30 0.29
Diabetes control 0.27 0.38
Energy and mobility 0.19 0.24
Table 4. Significant associations (p<0.05 and p<0.01) between HRQOL and the parameters investigated
  HRQOL High BP
High 
cholesterol
Diabetes 
control
Anxiety/
worry
Social 
burden
Sexual 
function
Energy/
mobility HBA1C
HRQOL 1
High BP –0.232** 1
High cholesterol –0.301** 0.607** 1
Diabetes control 0.745** –0.174* –0.306** 1
Anxiety/worry 0.781** –0.064 –0.171* 0.603** 1
Social burden 0.728** –0.076 –0.191** 0.573** 0.469** 1
Sexual function 0.667** –0.187** –0.167* 0.186** 0.344** 0.270** 1
Energy/mobility 0.606** –0.362** –0.294** 0.532** 0.296** 0.464** 0.167* 1
HBA1c –0.155* 0.069 0.041 –0.166* –0.045 –0.214** –0.082 –0.086 1
BP = blood pressure.
*Significant at the 0.05 level.
**Significant at the 0.01 level. Other cells not significant at any p-value.
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According to the American Diabetes Association, sexual dys func-
tion is one of the most common complications of DM and also one 
of the most underdiagnosed. Diabetic men are three times as likely 
as non-diabetic men to develop erectile dysfunction (ED). The cause 
is often multifactorial, but most commonly reflects endothelial 
dysfunction and autonomic neuropathy.[16] Studies have shown that 
sexual dysfunction, ED in particular, negatively affects QOL. The 
Exploratory Comprehensive Evaluation of Erectile Dysfunction study 
reported that among patients in the general population presenting to 
a urologist, ED negatively affected both general QOL and HRQOL.[16]
According to the Canadian Diabetes Association, little is known 
about the relationship between DM and anxiety.[17] The prevalence 
of anxiety disorders seems to higher in patients with diabetes 
(14%) than in the general population (3 - 4%). As many as 40% of 
diabetic patients have at least some anxiety symptoms.[17] Fear of 
hypoglycaemia is common in patients with DM, and while it may not 
affect HRQOL per se (e.g. it has little impact on pain or mobility), it 
can affect aspects of more general QOL (e.g. independence, ability to 
work or perform household duties, enjoyment of leisure activities). 
Sheu et al.[18] found that hypoglycaemic symptoms were associated 
with reduced QOL, as well as increased anxiety and worry, in 
diabetic patients treated with OHAs.[18] The present study found an 
association between anxiety and worry and HRQOL in patients with 
type 2 diabetes, whether they were treated with insulin alone or with 
OHAs.
The effects of lifestyle interventions in type 2 DM are relatively 
well described in the literature.[6,19,20] It has been noted that many 
such strategies can reduce the complications of type 2 DM. Lifestyle 
modification in relation to loss of weight, changing eating habits, 
cessation of cigarette smoking, reducing alcohol consumption and 
increasing physical exercise can play a major role in preventing 
complications related to DM. Although there has been substantial 
work on developing behavioural strategies to aid these lifestyle 
modifications, they are not easy to implement or to maintain on a 
long-term basis. Our study found no association between HRQOL 
and whether individuals drank alcohol and smoked cigarettes or 
not. However, although religious belief was not included in the 
questionnaire, our respondents included a substantial number of 
Muslims, who do not drink alcohol for religious reasons.
Clinicians need to keep a wide range of factors in mind when 
creating a treatment regimen for patients with DM. It is important to 
consider how DM affects each patient’s QOL, but resource constraints 
in the public sector make it a challenge to solve these problems. 
Psychological factors such as mental and physical strain need to be 
considered, together with costs associated with healthcare visits, 
days spent away from work, and loss of independence. Managing 
DM holistically by attempting to improve the psychological aspect of 
the patient’s disease as well as controlling blood glucose levels, blood 
pressure and cholesterol levels may lead to better HRQOL.
Study limitations
Global inferences are limited by the study design, duration and 
sample size and the fact that the study cohort represented a small 
group of patients, with poorly controlled blood glucose levels. 
Another limitation is that it was a non-random sample, conducted at 
a specialist diabetic clinic.
Conclusions
The results show an association between HbA1c and HRQOL. 
Furthermore, there was an association between HRQOL and HT 
and dyslipidaemia. No association was found between HRQOL and 
other clinical parameters, namely number of insulin units used per 
day, exercise, BMI, lipogram and the use of OHAs. Demographic 
parameters (age, gender, age at diagnosis, employment status and 
living arrangements) were also shown to have no impact on HRQOL 
in this study. Whether an individual consumed alcohol or smoked 
cigarettes did not affect his/her HRQOL.
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Appendix 1. The D-39 questionnaireDiabetes-­‐39	  
	  
Quality	  of	  Life	  Survey	  
	  
A	  person’s	  quality	  of	  life	  is	  affected	  by	  many	  things.	  	  These	  things	  might	  include	  health,	  the	  opportunity	  
for	  recreation	  and	  vacations,	  friends	  and	  family,	  and	  a	  job.	  	  This	  questionnaire	  is	  designed	  to	  help	  us	  learn	  
about	  what	  affects	  the	  quality	  of	  life	  of	  people	  with	  diabetes.	  
	  
Below	  are	  questions	  about	  your	  quality	  of	  life.	  	  For	  each	  factor	  listed,	  we	  ask	  you	  to	  place	  an	  “X”	  on	  the	  
line	  to	  show	  whether	  that	  factor	  affects	  your	  quality	  of	  life	  “extremely,”	  “not	  at	  all,”	  or	  some	  place	  in	  the	  
middle.	  	  An	  example	  is	  shown	  in	  the	  box	  below.	  	  For	  example,	  if	  you	  thought	  “having	  an	  automobile”	  
affected	  your	  quality	  of	  life	  to	  some	  extent,	  but	  not	  extremely,	  you	  might	  mark	  the	  line	  as	  shown.	  
	  
DURING	  THE	  PAST	  MONTH,	  HOW	  MUCH	  WAS	  THE	  QUALITY	  OF	  YOUR	  LIFE	  AFFECTED	  BY:	  
	   	   having	  an	  automobile	  
	   	   	   1___2___3___4___5_X_6___7	  
	   	   Not	  Affected	  	   	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
DURING	  THE	  PAST	  MONTH,	  HOW	  MUCH	  WAS	  THE	  QUALITY	  OF	  YOUR	  LIFE	  AFFECTED	  BY:	  
	  
1. Your	  diabetes	  medication	  schedule	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
2. Worries	  about	  money	  matters	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
3. Limited	  energy	  levels	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
4. Following	  your	  doctor’s	  prescribed	  treatment	  plan	  for	  diabetes	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
5. Food	  restrictions	  required	  to	  control	  your	  diabetes	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
6. Concerns	  about	  your	  future	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	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7. Other	  health	  problems	  besides	  diabetes	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
8. Stress	  or	  pressure	  in	  your	  life	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
9. Feelings	  of	  weakness	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
10. Restrictions	  on	  how	  far	  you	  can	  walk	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
11. Exercise	  requirements	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
12. Loss	  or	  blurring	  of	  your	  vision	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
13. Not	  being	  able	  to	  do	  what	  you	  want	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
14. Having	  diabetes	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
15. Losing	  control	  of	  your	  sugar	  levels	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
16. Other	  illnesses	  besides	  diabetes	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	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17. Testing	  your	  sugar	  (glucose)	  levels	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
18. The	  time	  required	  to	  control	  your	  diabetes	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
19. The	  restrictions	  your	  diabetes	  places	  on	  your	  family	  and	  friends	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
20. Being	  embarrassed	  because	  you	  have	  diabetes	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
21. Diabetes	  interfering	  with	  your	  sex	  life	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
22. Feeling	  blue	  or	  depressed	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
23. Problems	  with	  sexual	  functioning	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
24. Getting	  your	  diabetes	  well	  controlled	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
25. Complications	  from	  your	  diabetes	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
26. Doing	  things	  that	  your	  family	  or	  friends	  don’t	  do	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	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27. Keeping	  a	  record	  of	  your	  sugar	  levels	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
28. The	  need	  to	  eat	  at	  regular	  intervals	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
29. Not	  being	  able	  to	  do	  housework	  or	  other	  jobs	  around	  the	  house	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
30. A	  decreased	  interest	  in	  sex	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
31. Having	  your	  schedule	  center	  around	  diabetes	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
32. Needing	  to	  rest	  often	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
33. Problems	  in	  climbing	  steps	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
34. Having	  trouble	  caring	  for	  yourself	  (dressing,	  bathing,	  or	  using	  the	  toilet)	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
35. Restless	  sleep	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
36. Walking	  more	  slowly	  than	  others	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	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37. Being	  labeled	  a	  diabetic	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
38. Having	  diabetes	  interfere	  with	  your	  family	  life	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
39. Diabetes	  in	  general	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
	  
OVERALL	  RATINGS	  
1. Please	  place	  an	  “X”	  on	  the	  line	  below	  that	  indicates	  your	  rating	  of	  your	  overall	  quality	  of	  life.	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
2. Please	  place	  an	  “X”	  on	  the	  line	  below	  to	  show	  how	  severe	  you	  think	  your	  diabetes	  is.	  
	   	   	   1___2___3___4___5___6___7	  
	   	   Not	  Affected	  	   	   	   Extremely	  
	   	   	  	  	  	  At	  all	   	   	   	   Affected	  
	  
	  
